Mutations in ace2 gene modulate cytokine levels and alter immune responses in Mycobacterium tuberculosis and SARS-CoV-2 co-infection: a Cameroonian cohort
These biomarkers may reflect the complex interplay between the two pathogens and their impact on host immune responses and disease progression. This study highlights the critical role of genetic and immunological factors in shaping altered immune responses during co-infections involving Mtb and SARS-CoV-2. By elucidating these factors, the findings provide a foundation for a deeper understanding of host-pathogen interactions and their implications for disease progression and outcomes. Furthermore, this research has the potential to drive advancements in diagnostic approaches enabling more accurate detection and monitoring of co-infections.
Authors
- Séverin Donald Kamdem (ORCID: https://orcid.org/0000-0003-0183-8078)
- Ranjan Kumar Nanda (ORCID: https://orcid.org/0000-0002-2163-4411)
- John Amuasi (ORCID: https://orcid.org/0000-0002-8640-2662)
- Arnaud Tepa (ORCID: https://orcid.org/0000-0003-3763-7681)
- Jean Paul Assam Assam (ORCID: https://orcid.org/0000-0001-6601-2934)
- Anthony Afum-Adjei Awuah (ORCID: https://orcid.org/0000-0002-8912-9673)
- Eric Berenger Tchoupe (ORCID: https://orcid.org/0000-0001-5040-6795)
- Palmer Masumbe Netongo (ORCID: https://orcid.org/0000-0002-2341-6813)
- Fuh Roger Neba (ORCID: https://orcid.org/0000-0002-8815-9934)
- Nikhil Bhalla (ORCID: https://orcid.org/0000-0003-0584-5726)
- Mary Ngongang Kameni
Institutions
- Université de Yaoundé I (CM)
- University of Utah (US)
- Navajo Technical University (US)
- Kwame Nkrumah University of Science and Technology (GH)
- Kumasi Centre for Collaborative Research in Tropical Medicine (GH)
- International Centre for Genetic Engineering and Biotechnology (IN)
- Bernhard Nocht Institute for Tropical Medicine (DE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.3389/fimmu.2025.1533213
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- European and Developing Countries Clinical Trials Partnership